Suchergebnisse - "Behringer, Karolin"

PubPharm (46)

1

Patient-reported outcomes in Hodgkin lymphoma trials : a systematic review

enthalten in: Frontiers in oncology | 2024

von Oliva, E. | Ionova, T. | Laane, E. | +7

2

Relapse After Early-Stage, Favorable Hodgkin Lymphoma : Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Bröckelmann, P. | Müller, H. | Guhl, T. | +11

CommentIn: J Clin Oncol. 2021 Jan 10;39(2):97-99. - PMID 33275485

3

Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-Patients

enthalten in: Frontiers in oncology | 2021

von Rosenbrock, J. | Vásquez-Torres, A. | Mueller, H. | +11

4

Health-Related Quality of Life in Patients With Hodgkin Lymphoma : A Longitudinal Analysis of the German Hodgkin Study Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Kreissl, S. | Müller, H. | Goergen, H. | +15

CommentIn: J Clin Oncol. 2020 Sep 1;38(25):2821-2823. - PMID 32650684

5

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center

enthalten in: HemaSphere | 2019

von Momotow, J. | Goergen, H. | Behringer, K. | +6

6

Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment : results of a survey by the German Hodgkin Study Group

enthalten in: Leukemia & lymphoma | 2019

von Kreissl, S. | Goergen, H. | Müller, H. | +7

7

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma : A Comprehensive Analysis From the German Hodgkin Study Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Sasse, S. | Goergen, H. | Plütschow, A. | +14

8

Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women

enthalten in: Geburtshilfe und Frauenheilkunde | 2018

von Dittrich, R. | Kliesch, S. | Schüring, A. | +54

9

Fertility preservation for watients with malignant disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) : recommendations and statements for girls and women

enthalten in: Geburtshilfe und Frauenheilkunde | 2018

von Dittrich, R. | Kliesch, S. | Balcerek, M. | +34

10

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma : final analysis of a phase 2 randomised trial by the German Hodgkin Study Group

enthalten in: The Lancet. Oncology | 2017

von Eichenauer, D. | Plütschow, A. | Kreissl, S. | +14

CommentIn: Lancet Oncol. 2017 Dec;18(12):1566-1568. - PMID 29133015

1
2
3
4
5
Nächster »
[5]